Researchers have also found abnormal upregulation of IFN signals and different levels of IL-6 expression in inflammatory cells and muscle fibers in dermatomyositis, tofacitinib may also alleviate the active state of dermatomyositis by significantly down-regulating the transduction pathway [17, 18]. This evidence concerns the gene IL6 and dermatomyositis.